Stock listing

Medtide, Inc. Class H

Selected listing: FQ2 · FWB · EUR · DE

Medtide, Inc. Class H (Frankfurt:FQ2), Health Technology. Latest release Aug 5, 2026: CPC Scientific Announces U.S. FDA Pre-License Inspection (PLI)…

FQ2:FWBEURDEUpdated October 2, 2026
Medtide, Inc. Class H logo
Ticker
Frankfurt:FQ2
Asset type
Stock
Sector
Health Technology
Industry
Biotechnology
Exchange
Frankfurt
Currency
EUR

About Medtide, Inc. Class H

The company focuses on innovative solutions in its industry, contributing to advancements in healthcare. Investors can find detailed information about Medtide's operations and performance on its public company page.

Latest news from Medtide, Inc. Class H

CPC Scientific Announces U.S. FDA Pre-License Inspection (PLI) Successfully Completed at Its Hangzhou cGMP Manufacturing Facility for Hepcludex® API, Establishing a Proven Track Record Under the Stringent BLA Pathway

August 5, 2026

ARTICLES OF ASSOCIATION

June 18, 2026

All Medtide, Inc. Class H news →

Research Medtide, Inc. Class H

Medtide, Inc. Class H company profile

View the public company page for Medtide, Inc. Class H on 6ix.

Medtide, Inc. Class H news

Read company news and market updates connected to Medtide, Inc. Class H.

Medtide, Inc. Class H investor events

Find investor webinars, events, and replay context for Medtide, Inc. Class H.

Alternate listings

3880:HKEX

HK · HKD

Alternate listing for Medtide, Inc. Class H; the primary context on this page is FQ2:FWB.